CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 52 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,202 | -22.3% | 83,000 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $92,960 | +7.7% | 83,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $86,320 | -7.1% | 83,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $92,960 | +54.9% | 83,000 | +56.6% | 0.01% | +50.0% |
| Q3 2022 | $60,000 | -23.1% | 53,000 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $78,000 | -35.5% | 53,000 | 0.0% | 0.01% | -28.6% |
| Q1 2022 | $121,000 | -17.1% | 53,000 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $146,000 | +87.2% | 53,000 | +307.7% | 0.01% | +80.0% |
| Q3 2021 | $78,000 | +59.2% | 13,000 | +30.0% | 0.01% | +66.7% |
| Q2 2021 | $49,000 | +96.0% | 10,000 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $25,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 169,629 | $147,560 | 0.05% |
| BROWN WEALTH MANAGEMENT, LLC | 110,000 | $95,689 | 0.05% |
| Carmignac Gestion | 2,132,744 | $1,855,274 | 0.03% |
| WATER ISLAND CAPITAL LLC | 82,500 | $72 | 0.01% |
| Northeast Financial Consultants Inc | 83,000 | $72,202 | 0.01% |
| XTX Topco Ltd | 27,545 | $23,961 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,600 | $152,754 | 0.00% |
| Curi Wealth Management, LLC | 25,000 | $21,748 | 0.00% |
| Banque Cantonale Vaudoise | 40,000 | $35 | 0.00% |
| SYNOVUS FINANCIAL CORP | 58,071 | $50,516 | 0.00% |